Nan Wang, Master student

Department of Pharmacy
Beijing Children’s Hospital, Capital Medical University,
Beijing, Beijing, China (People's Republic)

Nan Wang is a Master of Science student at China Pharmaceutical University, majoring in clinical pharmacy, and an intern at Beijing Children's Hospital, Capital Medical University. She is studying individualised TPO-RA therapy for children with ITP. Her work has been published in the British Journal of Haematology, Pediatric Investigation and other venues.

Presentation(s):

• OC 13.4 - Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China

  Sunday, June 23, 2024
  10:15 – 10:30 ICT

• PB0721 - Case Report: Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0604 - Plasma concentration-adjusted dose of eltrombopag for the individualised treatment of immune thrombocytopenia in children：apilot study from Beijing Children’s Hospital

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0613 - Real-World Use of Emicizumab in Chinese Children with Hemophilia A: Retrospective Data from a Comprehensive Care Center

  Monday, June 24, 2024
  13:45 – 14:45 ICT